ArticleAngewandte Chemie (International ed. in English)2025
NIR-Activatable, Sequence-Specific Metal-Nucleic Acid Scaffolds for Responsive Uncaging.
Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pt(iv) scaffold effects on nucleolar stress and DNA damage response pathways.RSC chemical biology · 2026Article
- NIR-Activatable, Sequence-Specific Metal-Nucleic Acid Scaffolds for Responsive Uncaging.Angewandte Chemie (International ed. in English) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Precise molecular activation with both analyte specificity and spatiotemporal control remains a major challenge in responsive diagnostics, targeted therapies, and the study of complex biological systems. Traditional photo-uncaging strategies offer excellent temporal resolution but suffer from limited tissue penetration and poor biological specificity, while analyte-responsive platforms provide molecular selectivity without external control. Here, we introduce sequence-responsive diagnostic uncaging-a unique approach that integrates nucleic acid recognition with near-infrared (NIR)-triggered molecular activation within a metal-nucleic acid scaffold. This platform is built upon a first-of-its-kind Pt(IV)-DNA molecular scaffold, modularly assembled via click chemistry, and integrates a Pt(IV)-caged reporter, a nucleic acid recognition domain, and an NIR antenna (e.g., IR800). Notably, DNA-mediated electron transfer (DNA-MET) provides a long-range ET pathway to direct photoreduction of the Pt(IV) centers, enabling "responsive uncaging" that occurs only upon hybridization with a fully complementary DNA or miRNA strand. Upon NIR irradiation, the duplexed nucleic acid system facilitates electron transfer from the excited antenna to Pt(IV), triggering the release of fluorescent reporters. Using two Pt(IV)-caged fluorophores (MCA and BDP), we demonstrate efficient uncaging and high sequence specificity in both solution and live cells. This platform offers a powerful and versatile photochemical tool that seamlessly bridges diagnostics and molecular activation, with broad implications for precision medicine, targeted drug delivery, and next-generation biosensing technologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.